International Network of VENous Thromboembolism Clinical Research Networks

A A
Print screen
Search
close
Toggle menu
Flag of Ireland

INViTE

The Irish Network for VTE Research (INViTE) is an Irish, patient-oriented research network aimed at developing and participating in excellent National and International venous thromboembolism (VTE)-related research. We are honoured to work with the patient group Thrombosis Ireland at every step along the way of study concept, design and development

Council Members

Etimbuk Umana

Etimbuk Umana, MD PhD FRCEM 

Etimbuk Umana is a Consultant in Emergency Medicine with a special interest in Venous Thromboembolism (VTE). He works at the Mater Misericordiae University Hospital (MMUH) in Dublin and serves as the Vice Director for the Irish Network for VTE Research (INViTE).

His research interests include VTE in trauma, where he collaborated with Dr. Bibi Bassa on the VTE in Trauma eVALuation (VITAL) research program. He also served as the Principal Investigator for the COBRRA study (Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute VTE) in collaboration with Assoc. Prof. Lana Castellucci.
Fionnuala Ní Áinle

Fionnuala Ní Áinle, MB, PhD

Fionnuala Ní Ainle is a Consultant Haematologist at the Mater Misericordiae University Hospital (MMUH) and Rotunda Maternity Hospital, Dublin. She is also a Professor in the School of Medicine, UCD. She is privileged to treat patients affected with thrombosis and has a strong interest in women’s issues in thrombosis and haemostasis. She acts as Chair of her Hospital and Regional venous thromboembolism (VTE) committees and is a founder member of VTE Ireland, a National Clinical VTE Working Group. She is co-organizer of the “VTE Dublin” thrombosis conference.

Her research interests explore the role of blood coagulation and extracellular vesicles in the aetiology, management and therapy of clinical disorders, particularly disorders of pregnancy. Along with Assoc. Prof. Patricia Maguire, she co-directs the UCD Conway Institute SPHERE Research Group and is actively involved in international clinical trials.